Eaton Vance Management Integra Lifesciences Holdings Corp Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Eaton Vance Management holds 4,215,548 shares of IART stock, worth $58 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

4,215,548

Previous 4,226,696 0.26%

Holding current value

$58 Million

Previous $228 Million 21.81%

% of portfolio

0.26%

Previous 0.32%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$42.28 - $57.17 $471,337 - $637,331	-11,148 Reduced 0.26%	4,215,548 $179 Million
Q2 2022 Aug 15, 2022	BUY	$53.86 - $66.52 $566,714 - $699,923	10,522 Added 0.25%	4,226,696 $228 Million
Q1 2022 May 16, 2022	BUY	$62.86 - $69.24 $6.84 Million - $7.54 Million	108,831 Added 2.65%	4,216,174 $271 Million
Q4 2021 Feb 14, 2022	BUY	$62.47 - $73.25 $6.47 Million - $7.58 Million	103,505 Added 2.59%	4,107,343 $275 Million
Q3 2021 Nov 15, 2021	BUY	$64.97 - $76.19 $69 Million - $80.9 Million	1,061,750 Added 36.09%	4,003,838 $274 Million
Q2 2021 Aug 16, 2021	BUY	$66.79 - $76.63 $14 Million - $16.1 Million	209,534 Added 7.67%	2,942,088 $201 Million
Q1 2021 May 17, 2021	BUY	$62.63 - $71.15 $15.4 Million - $17.4 Million	245,121 Added 9.85%	2,732,554 $189 Million
Q4 2020 Feb 12, 2021	BUY	$43.31 - $66.55 $34.3 Million - $52.7 Million	792,588 Added 46.76%	2,487,433 $161 Million
Q3 2020 Nov 13, 2020	BUY	$43.33 - $51.72 $2.35 Million - $2.81 Million	54,307 Added 3.31%	1,694,845 $80 Million
Q2 2020 Nov 20, 2020	BUY	$41.42 - $55.57 $414 - $555	10 Added 0.0%	1,640,538 $77.1 Million
Q2 2020 Aug 13, 2020	BUY	$41.42 - $55.57 $25 Million - $33.5 Million	602,492 Added 58.04%	1,640,528 $77.1 Million
Q1 2020 May 14, 2020	BUY	$36.67 - $61.04 $21.2 Million - $35.4 Million	579,159 Added 126.21%	1,038,036 $46.4 Million
Q4 2019 Feb 11, 2020	BUY	$55.73 - $62.49 $14.1 Million - $15.8 Million	253,545 Added 123.48%	458,877 $26.7 Million
Q3 2019 Nov 14, 2019	BUY	$53.29 - $64.59 $4.51 Million - $5.46 Million	84,552 Added 70.0%	205,332 $12.3 Million
Q2 2019 Aug 16, 2019	BUY	$46.45 - $55.85 $580,206 - $697,622	12,491 Added 11.53%	120,780 $6.74 Million
Q1 2019 May 14, 2019	SELL	$42.97 - $57.33 $21,656 - $28,894	-504 Reduced 0.46%	108,289 $6.03 Million
Q4 2018 Feb 07, 2019	SELL	$42.62 - $64.51 $69,214 - $104,764	-1,624 Reduced 1.47%	108,793 $4.91 Million
Q3 2018 Nov 13, 2018	SELL	$57.63 - $65.87 $92,150 - $105,326	-1,599 Reduced 1.43%	110,417 $7.27 Million
Q2 2018 Aug 10, 2018	SELL	$54.05 - $67.23 $1.25 Million - $1.56 Million	-23,151 Reduced 17.13%	112,016 $7.22 Million
Q1 2018 May 07, 2018	BUY	$46.55 - $57.38 $148,820 - $183,443	3,197 Added 2.42%	135,167 $7.48 Million
Q4 2017 Feb 12, 2018	SELL	$46.22 - $51.77 $3.77 Million - $4.23 Million	-81,632 Reduced 38.22%	131,970 $6.32 Million
Q3 2017 Nov 13, 2017	BUY	$47.8 - $53.63 $10.2 Million - $11.5 Million	213,602	213,602 $10.8 Million

Others Institutions Holding IART

# of Institutions

232

Shares Held

79.5M

Call Options Held

24.6K

Put Options Held

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.15B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Integra Lifesciences Holdings Corp Transaction History